acitretin/etretinate embryopathy
Acitretin/Etretinate embryopathy is a teratogenic disorder due to acitretin or etretinate exposure during the first trimester of pregnancy, carrying a risk of fetal malformations of approximately 20%, including central nervous system, craniofacial, ear, thymic, cardiac and limb anomalies. [ Orphanet:40366 ]
Term info
- GARD:0000468 (MONDO:equivalentTo)
- Orphanet:40366 (MONDO:equivalentTo)
- SCTID:725287006 (MONDO:equivalentTo)
- UMLS:CN205049 (MONDO:equivalentTo)
- MESH:C538169 (MONDO:equivalentTo)
gard_rare, ordo_disease
Acitretin/Etretinate embryopathy is a teratogenic disorder due to acitretin or etretinate exposure during the first trimester of pregnancy, carrying a risk of fetal malformations of approximately 20%, including central nervous system, craniofacial, ear, thymic, cardiac and limb anomalies.
http://linkedlifedata.com/resource/umls/id/CN205049, http://identifiers.org/mesh/C538169, http://identifiers.org/snomedct/725287006, http://purl.obolibrary.org/obo/Orphanet_40366
fetal acitretin/etretinate syndrome, retinoid embryopathy
Acitretine embryofetopathy, acitretin embryofetopathy, fetal acitretin syndrome, acitretin embryopathy
MONDO:0018442
https://rarediseases.info.nih.gov/diseases/468/acitretin-embryopathy